Seeking Alpha

Cougar Biotechnology (CGRB)

()

Comments on CGRB

  • Biotech: Q3 Market Update [View article]
    Thank you for the market numbers, well researched. Keep posting.
    Comment by cyrussmith123
    Dec 18 01:23 am |
    Rating: 0 0
  • Cougar Biotechnology: Stalking Prostate Cancer [View article]
    A doctor told my partner that prostate stimulation can help as a preventative action towards prostate cancer. What are your thoughts on... More »
    Oct 7 15:20 pm |
    Rating: 0 0
  • Healthcare companies still desperate for a partner [View instapost]
    NeurogesX: Astellas Deal a Major Positive by: Zacks.com June 22, 2009 | about: ALPMF.PK / NGSX By Jason... More »
    Comment by Janine McCargo
    Jun 30 15:25 pm |
    Rating: 0 0
  • Healthcare companies still desperate for a partner [View instapost]
    You think Dendreon is desperate? I think you are Clueless! Dendreon WHEN they announce their Partner it will be a Shell SHOCK as to the... More »
    Comment by USisCorrupt
    Jun 30 13:50 pm |
    Rating: +1 -1
  • Healthcare companies still desperate for a partner [View instapost]
    You think Dendreon is desperate? I think you are Clueless! Dendreon WHEN they announce their Partner it will be a Shell SHOCK as to the... More »
    Comment by USisCorrupt
    Jun 30 13:50 pm |
    Rating: +1 -1
  • Healthcare companies still desperate for a partner [View instapost]
    I think you made a mistake in your cut and paste. Poniard's Picoplatin and Arena's Lorcaserin are in phase 3.
    Comment by Jolly_Rancher
    Jun 30 13:33 pm |
    Rating: 0 0
  • Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer [View article]
    As we have been highlighting since ASCO, prostate cancer remains in vogue with investors. Medarex (MEDX) now surging today on Mayo... More »
    Comment by Michael Becker
    Jun 22 11:10 am |
    Rating: 0 0
  • Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer [View article]
    In reviewing all 29 of your comments throughout SeekingAlpha, I noticed that all of them promote ACCP. However, my article referencing... More »
    Comment by Michael Becker
    Jun 20 10:02 am |
    Rating: 0 0
  • Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer [View article]
    Greg - I read some of your various comments and it appears that you also know a thing or two about the industry. Beyond focusing on the... More »
    Comment by Michael Becker
    Jun 20 09:49 am |
    Rating: 0 0
  • Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer [View article]
    Thanks for your article. It's refreshing to read articles related to the biotech/pharma sector from someone knowledgeable in how drug... More »
    Comment by Greg Parker
    Jun 20 09:40 am |
    Rating: +2 0
  • Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer [View article]
    GNBT has a prostrate cancer vaccine that was recently in the news with positive test results as well. Trying to find more and... More »
    Comment by guitarz
    Jun 19 23:07 pm |
    Rating: 0 -1
  • Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer [View article]
    you mention PARD, another company working on a new and improved platinum drug is ACCP:... More »
    Comment by svygear
    Jun 19 15:50 pm |
    Rating: 0 -1
  • Biotech Stocks and the ASCO-Effect [View article]
    Post-ASCO, new 52-week high today - OncoGenex Pharmaceuticals, Inc. (OGXI)
    Comment by Michael Becker
    Jun 4 12:08 pm |
    Rating: 0 0
  • Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly [View article]
    MARK CIFRA-Since you are so informative to many investors, and helpful, I see you left out one stock that needs to be addressed... More »
    Comment by jimmy Turano
    Jun 3 18:59 pm |
    Rating: +1 0
  • Access Pharma: A Smallcap Cancer Biotech Call Option Trade [View article]
    Mike Oh well he must have checked out for now.....
    Comment by fwallace55
    Jun 2 06:22 am |
    Rating: 0 0